Albert Friedberg

Albert Friedberg (board member) discloses dealings in Vaccinex, Inc. to SEC (Form 4). Over a trading history stretching from 13 August 2018 to 14 November 2024, the count stands at 54 filings.

Every open-market trade on record is a purchase: 37 purchases worth €48.4M, and no sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 6 share grants and 2 option exercises. In 2024 alone, the filings show 10 purchases and no sales.

In size, the median ticket on the buying side is €12k. On 2 out of 27 purchases, another insider of the same company was buying within the same 30 days. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.

On 18 November 2024 came the latest disclosure, a share grant for €95k in Vaccinex, Inc. The last purchase on record was published on 13 August 2024, which is 817 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.